SEC Comment Letter for Minerva Neurosciences, Inc. (NERV) (CIK 0001598646) (NERV) — Aug 20, 2018
Minerva Neurosciences, Inc. (NERV) (CIK 0001598646)
Date: Aug. 20, 2018 · CIK: 0001598646 · Accession: 0000000000-18-025681
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-226783
Letter
August 17, 2018 Remy Luthringer, Ph.D. Chief Executive Officer Minerva Neurosciences, Inc. 1601 Trapelo Road Suite 286 Waltham, MA 02451 Re:Minerva Neurosciences, Inc. Registration Statement on Form S-3 Filed August 10, 2018 File No. 333-226783 Dear Dr. Luthringer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Ryan Sansom, Esq.
Show Raw Text
August 17, 2018
Remy Luthringer, Ph.D.
Chief Executive Officer
Minerva Neurosciences, Inc.
1601 Trapelo Road
Suite 286
Waltham, MA 02451
Re:Minerva Neurosciences, Inc.
Registration Statement on Form S-3
Filed August 10, 2018
File No. 333-226783
Dear Dr. Luthringer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Ryan Sansom, Esq.